missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ SRSF2 Recombinant Rabbit Monoclonal Antibody (K01_1Y11)
Description
Immunogen sequence: VRFHDKRDAE DAMD.
The protein encoded by SC35 is a member of the serine/arginine (SR)-rich family of pre-mRNA splicing factors, which constitute part of the spliceosome. Each of these factors contains an RNA recognition motif (RRM) for binding RNA and an RS domain for binding other proteins. The RS domain is rich in serine and arginine residues and facilitates interaction between different SR splicing factors. In addition to being critical for mRNA splicing, the SR proteins have also been shown to be involved in mRNA export from the nucleus and in translation. Two transcript variants encoding the same protein and one non-coding transcript variant have been found for SC35. In addition, a pseudogene of SC35 has been found on chromosome 11.
Specifications
Specifications
| Antigen | SRSF2 |
| Applications | Immunohistochemistry (Paraffin), Western Blot |
| Classification | Recombinant Monoclonal |
| Clone | K01_1Y11 |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 50mM tris glycine with 40% glycerol, 0.05% BSA, 150mM NaCl and 0.01% sodium azide; pH 7.4 |
| Gene | SRSF2 |
| Gene Accession No. | Q01130, Q6PDU1 |
| Gene Alias | D11Wsu175e; MRF-1; myelin regulatory factor 1; Pr264; Protein PR264; Putative myelin regulatory factor 1; SC35; SC-35; serine and arginine rich splicing factor 2; serine/arginine-rich splicing factor 2; Sfrs10; Sfrs2; SFRS2A; splicing component, 35 kDa; Splicing factor SC35; splicing factor, arginine/serine-rich 2; splicing factor, arginine/serine-rich 2 (SC-35); SR splicing factor 2; SRp30b; Srsf2 |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?